Umecrine Cognition

Website

Developer of pharmaceutical drugs designed to treat cognitive neurological disorders. The company offers drugs for the treatment of symptoms in the central nervous system related to chronic neuroinfla...

Healthcare
Solna, Sweden
Founded 2006
3 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$28.1M
Last Round
N/A
Investors
+8 other investors
View all 8 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Umecrine Cognition's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required